Tumor suppressor gene, p28ing5
AssigneeThe United States of America as represented by the Department of Health and Human Services
InventorsCurtis Harris, Remy Pedeux, Makoto Nagashima, Masayuki Shiseki
Life of this patent
Estimating the term…
Abstract
This disclosure provides a novel tumor suppressor, referred to as p28ING5, nucleic acid molecules encoding this protein, and methods of making and using these molecules. Also provided are methods of ameliorating, treating, detecting, prognosing, and diagnosing diseases and conditions associated with abnormal p28ING5 expression, such as neoplasia. Kits are also provided.
Claims42
A purified p28ING5 tumor suppressor protein having a sequence comprising amino acid residues 1-13 and 241-356 of SEQ ID NO:
- 2, or a sequence having one or more conservative substitutions thereof.
An in vitro assay kit for determining whether or not a subject has a biological condition associated with p28ING5 expression by detecting an underabundance of p28ING5 protein in a sample of tissue and/or body fluids from the subject, comprising:
- a container comprising an antibody specific for p28ING5 protein;
- and
- instructions for using the kit, the instructions indicating steps for performing a method to detect the presence of p28ING5 protein in the sample;
- and
- analyzing data generated by the method, wherein the instructions indicate that underabundance of p28ING5 protein in the sample indicates that the individual has the biological condition.
An in vitro amplification assay kit for determining whether or not a subject has a biological condition associated with a p28ING5 nucleic acid by detecting presence and/or quantity of a nucleic acid that encodes p28ING5 protein in a sample of tissue and/or body fluids from the subject, the kit comprising:
- a first container comprising an in vitro amplification primer that specifically amplifies the nucleic acid that encodes p28ING5 protein;
- a second container comprising a size marker, the size marker being the expected size of amplified DNA if the nucleic acid that encodes p28ING5 protein is present in the sample;
- and
- instructions for using the kit, wherein the instructions indicate steps for performing a method to detect and/or quantify the nucleic acid that encodes p28ING5 protein in the sample;
- and analyzing data generated by the method, wherein the instructions indicate that the presence of increased nucleic acid that encodes p28ING5 protein in the sample indicates that the subject has the biological condition.
Dependencies are inferred from the claim text.